Combination of cytology, fluorescence in situ hybridization for aneuploidy, and reverse-transcriptase polymerase chain reaction for human mammaglobin/mammaglobin B expression improves diagnosis of malignant effusions

Journal of Clinical Oncology

Volumn 22, Issue 3, 2004, Pages 474-483

  Fiegl, Michael ^a   Haun, Margot ^a   Massoner, Anita ^a   Krugmann, Jens ^a   Müller Holzner, Elisabeth ^a   Hack, Rene ^a   Hilbe, Wolfgang ^a   Marth, Christian ^a   Duba, Hans Christoph ^a   Gastl, Günther ^a   Grünewald, Kurt ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMAGLOBIN; MAMMAGLOBIN B; UNCLASSIFIED DRUG; MESSENGER RNA; RNA; TUMOR MARKER; TUMOR PROTEIN; UTEROGLOBIN;

ANEUPLOIDY; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; EFFUSION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR CELL; ASCITES FLUID; COMPARATIVE STUDY; EPITHELIUM CELL; FEMALE; GENETICS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PLEURA EFFUSION;

ANEUPLOIDY; ASCITIC FLUID; CYTOLOGICAL TECHNIQUES; EPITHELIAL CELLS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM PROTEINS; NEOPLASMS; PLEURAL EFFUSION, MALIGNANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 1442339456     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.063     Document Type: Article

References (48)

1. Nagy JA, Masse EM, Herzberg KT, et al: Pathogenesis of ascites tumor growth: Vascular permeability factor, vascular hyperpermeability, and ascites fluid accumulation. Cancer Res 55: 360-368, 1995
2. Starr RL, Sherman ME: The value of multiple preparations in the diagnosis of malignant pleural effusions: A cost-benefit analysis. Acta Cytol 35:533-537, 1991
3. Fiegl M, Kaufmann H, Zojer N, et al: Malignant cell detection by fluorescence in situ hybridization (FISH) in effusions from patients with carcinoma. Hum Pathol 31:448-455, 2000
4. Zojer N, Fiegl M, Angerler J, et al: Interphase fluorescence in situ hybridization improves the detection of malignant cells in effusions from breast cancer patients. Br J Cancer 75:403-407, 1997
5. Chen Z, Wang DD, Peier A, et al: FISH in the evaluation of pleural and ascitic fluids. Cancer Genet Cytogenet 84:116-119, 1995
6. van Oostenbrugge RJ, Hopman AH, Arends JW, et al: Treatment of leptomeningeal metastases evaluated by interphase cytogenetics. J Clin Oncol 18:2053-2058, 2000
7. Cajulis RS, Haines GK III, Frias-Hidvegi D, et al: Interphase cytogenetics as an adjunct in the cytodiagnosis of urinary bladder carcinoma: A comparative study of cytology, flow cytometry and interphase cytogenetics in bladder washes. Anal Quant Cytol Histol 16:1-10, 1994
8. Schenk T, Ackermann J, Brunner C, et al: Detection of chromosomal aneuploidy by interphase fluorescence in situ hybridization in bronchoscopically gained cells from lung cancer patients. Chest 111:1691-1696, 1997
9. Grünewald K, Haun M, Fiegl M, et al: Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest 82:1147-1153, 2002
10. Sakaguchi M, Virmani AK, Ashfaq R, et al: Development of a sensitive, specific reverse transcriptase polymerase chain reaction-based assay for epithelial tumour cells in effusions. Br J Cancer 79:416-422, 1999
11. Okamoto I, Morisaki T, Sasaki J, et al: Molecular detection of cancer cells by competitive reverse transcription-polymerase chain reaction analysis of specific CD44 variant RNAs. J Natl Cancer Inst 90:307-315, 1998
12. Dai Y, Morishita Y, Mase K, et al: Application of the p53 and K-ras gene mutation patterns for cytologic diagnosis of recurrent lung carcinomas. Cancer 90:258-263, 2000
13. Yamashita K, Kuba T, Shinoda H, et al: Detection of K-ras point mutations in the supernatants of peritoneal and pleural effusions for diagnosis complementary to cytologic examination. Am J Clin Pathol 109:704-711, 1998
14. Yu CJ, Shew JY, Liaw YS, et al: Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion. Am J Respir Crit Care Med 164:1312-1318, 2001
15. Yang CT, Lee MH, Lan RS, et al: Telomerase activity in pleural effusions: Diagnostic significance. J Clin Oncol 16:567-573, 1998
16. Davidson B, Lazarovici P, Ezersky A, et al: Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients. Clin Cancer Res 7:3457-3464, 2001
17. Watson MA, Fleming TP: Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. Cancer Res 56:860-865, 1996
18. Becker RM, Darrow C, Zimonjic DB, et al: Identification of mammaglobin B, a novel member of the uteroglobin gene family. Genomics 54:70-78, 1998
19. Aihara T, Fujiwara Y, Ooka M, et al: Mammaglobin B as a novel marker for detection of breast cancer micrometastases in axillary lymph nodes by reverse transcription-polymerase chain reaction. Breast Cancer Res Treat 58:137-140, 1999
20. Fiegl M, Tueni C, Schenk T, et al: Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer. Br J Cancer 72:51-55, 1995
21. Eastmond DA, Schuler M, Rupa DS: Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutation Res 348:153-162, 1995
22. Fiegl M, Zojer N, Kaufmann H, et al: Hyperdiploidy and apparent aneusomy in mesothelial cells from non-malignant effusions as detected by fluorescence in situ hybridization (FISH). Cytometry (Comm Clin Cytometry) 38:15-23, 1999
23. von Weizsacker F, Labeit S, Koch HK, et al: A simple and rapid method for the detection of RNA in formalin-fixed, paraffin-embedded tissues by PCR amplification. Biochem Biophys Res Commun 174:176-180, 1991
24. Grünewald K, Haun M, Urbanek M, et al: Mammaglobin gene expression: A superior marker of breast cancer cells in peripheral blood in comparison to epidermal-growth-factor receptor and cytokeratin-19. Lab Invest 80:1071-1077, 2000
25. Zach O, Kasparu H, Krieger O, et al: Detection of circulating mammary carcinoma cells in the peripheral blood of breast cancer patients via a nested reverse transcriptase polymerase chain reaction assay for mammaglobin mRNA. J Clin Oncol 17:2015-2019, 1999
26. Runyon BA, Montano AA, Akriviadis EA, et al: The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 117:215-220, 1992
27. Light RW: Clinical practice: Pleural effusion. N Engl J Med 346:1971-1977, 2002
28. Ashchi M, Golish J, Eng P, et al: Transudative malignant pleural effusions: Prevalence and mechanisms. South Med J 91:23-26, 1998
29. Moltyaner Y, Miletin MS, Grossman RF: Transudative pleural effusions: False reassurance against malignancy. Chest 118:885, 2000
30. Castro DJ, Nuevo GD, Perez-Rodriguez E: Cytologically proved malignant pleural effusions. Chest 114:1798, 1998
31. Lossos IS, Breuer R, Intrator O, et al: Differential diagnosis of pleural effusion by lactate dehydrogenase isoenzyme analysis. Chest 111:648-651, 1997
32. Mezger J, Permanetter W, Gerbes AL, et al: Tumour associated antigens in diagnosis of serous effusions. J Clin Pathol 41:633-643, 1988
33. Mitelman F, Johansson B, Mandahl N, et al: Clinical significance of cytogenetic findings in solid tumors. Cancer Genet Cytogenet 95:1-8, 1997
34. Fehm T, Sagalowsky A, Clifford E, et al: Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8:2073-2084, 2002
35. Chang HW, Ali SZ, Cho SK, et al: Detection of allelic imbalance in ascitic supernatant by digital single nucleotide polymorphism analysis. Clin Cancer Res 8:2580-2585, 2002
36. Mitas M, Mikhitarian K, Walters C, et al: Quantitative real-time RT-PCR detection of breast cancer micrometastasis using a multigene marker panel. Int J Cancer 93:162-171, 2001
37. Min CJ, Tafra L, Verbanac KM: Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes. Cancer Res 58:4581-4584, 1998
38. Okami J, Dohno K, Sakon M, et al: Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 6:2326-2332, 2000
39. Watson MA, Dintzis S, Darrow CM, et al: Mammaglobin expression in primary, metastatic, and occult breast cancer. Cancer Res 59:3028-3031, 1999
40. Hallman JR, Geisinger KR: Cytology of fluids from pleural, peritoneal and pericardial cavities in children: A comprehensive survey. Acta Cytol 38:209-217, 1994
41. Kutty CP, Remeniuk E, Varkey B: Malignant-appearing cells in pleural effusion due to pancreatitis: Case report and literature review. Acta Cytol 25:412-416, 1981
42. Koss LG: Morphologic characteristics of cancer cells, in Diagnostic Cytology and Its Histopathologic Bases. Philadelphia, PA, Lippincott, 1992, pp 118-147
43. Spriggs AI, Boddington MM: Oat-cell bronchial carcinoma: Identification of cells in pleural fluid. Acta Cytol 20:525-529, 1976
44. Kruger WH, Jung R, Detlefsen B, et al: Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells. Med Oncol 18:33-38, 2001
45. Suchy B, Austrup F, Driesel G, et al: Detection of mammaglobin expressing cells in blood of breast cancer patients. Cancer Lett 158:171-178, 2000
46. Buhr J, Berghauser KH, Gonner S, et al: The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer. J Thorac Cardiovasc Surg 113:683-690, 1997
47. Hermanek P, Hutter RV, Sobin LH, et al: International Union Against Cancer: Classification of isolated tumor cells and micrometastasis. Cancer 86:2668-2673, 1999
48. Aihara T, Fujiwara Y, Miyake Y, et al: Mammaglobin B gene as a novel marker for lymph node micrometastasis in patients with abdominal cancers. Cancer Lett 150:79-84, 2000